OKYO Pharma OKYO
NASDAQ OKYO
$1.30 +0.00 (+0.00%)
As of: Oct 1, 2026 · 11:18 AM EDT

OKYO Pharma (OKYO) Change in Receivables (2025 - 2026)

Updated

OKYO Pharma's Change in Receivables came in at $101,317 for the quarter ended Mar 31, 2026, up 13.2% from the prior quarter.

Analysis

OKYO Pharma (OKYO) Change in Receivables (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma's Change in Receivables was $10,914.

  • Change in Receivables carries a five-year compound annual growth rate of -44.6% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Change in Receivables was -$90,403 in the year ended Mar 31, 2025, $440,257 in the year ended Dec 31, 2024 (+162.5%), $167,718 in the year ended Dec 31, 2023 and -$802,154 in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 OKYO Pharma 867.87 Mn 867.87 Mn - 101,317.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 101,317.00
Dec 31, 2025 89,536.00
API Access

OKYO Pharma Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=OKYO&period=max&api_key=YOUR_API_KEY